Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Protein Science : a Publication of the Protein Society
|
March 21, 2025
Data-driven evaluation of suitable immunogens for improved antibody selection
Katharina Waury, Hlin Kvartsberg, Henrik Zetterberg, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2025
Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
Burak Arslan, Elzbieta Rembeza, Sofia Rasch, et al.
Alzheimer'S Research & Therapy
|
February 9, 2021
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias
Claudia Cicognola, Oskar Hansson, Philip Scheltens, et al.
European Journal of Neurology
|
April 17, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis
Igal Rosenstein, Markus Axelsson, Magnus Johnsson, et al.
Alzheimer'S Research & Therapy
|
November 18, 2020
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Victor Bloniecki, Henrik Zetterberg, Dag Aarsland, et al.
Clinical Chemistry and Laboratory Medicine
|
April 29, 2026
Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory
Burak Arslan, Johan Gobom, Joel Simrén, et al.
Acta Neuropathologica
|
September 24, 2018
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease
Hlin Kvartsberg, Tammaryn Lashley, Christina E Murray, et al.
Journal of Neurochemistry
|
November 29, 2020
Molecular forms of neurogranin in cerebrospinal fluid
Faisal Hayat Nazir, Elena Camporesi, Gunnar Brinkmalm, et al.
Clinical Chemistry and Laboratory Medicine
|
July 21, 2023
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Francisco Meda, Joel Simrén, Barbara Borroni, et al.
Alzheimer'S Research & Therapy
|
December 23, 2020
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
Annika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Protein Science : a Publication of the Protein Society
|
March 21, 2025
Data-driven evaluation of suitable immunogens for improved antibody selection
Katharina Waury, Hlin Kvartsberg, Henrik Zetterberg, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2025
Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
Burak Arslan, Elzbieta Rembeza, Sofia Rasch, et al.
Alzheimer'S Research & Therapy
|
February 9, 2021
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias
Claudia Cicognola, Oskar Hansson, Philip Scheltens, et al.
European Journal of Neurology
|
April 17, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis
Igal Rosenstein, Markus Axelsson, Magnus Johnsson, et al.
Alzheimer'S Research & Therapy
|
November 18, 2020
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Victor Bloniecki, Henrik Zetterberg, Dag Aarsland, et al.
Clinical Chemistry and Laboratory Medicine
|
April 29, 2026
Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory
Burak Arslan, Johan Gobom, Joel Simrén, et al.
Acta Neuropathologica
|
September 24, 2018
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease
Hlin Kvartsberg, Tammaryn Lashley, Christina E Murray, et al.
Journal of Neurochemistry
|
November 29, 2020
Molecular forms of neurogranin in cerebrospinal fluid
Faisal Hayat Nazir, Elena Camporesi, Gunnar Brinkmalm, et al.
Clinical Chemistry and Laboratory Medicine
|
July 21, 2023
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Francisco Meda, Joel Simrén, Barbara Borroni, et al.
Alzheimer'S Research & Therapy
|
December 23, 2020
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
Annika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, et al.
Page
of 6